Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solmaz Sahebjam

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|December 8, 2025
Successful response in advanced leptomeningeal disease from pleomorphic xanthoastrocytoma with BRAF/MEK inhibitors: a case reportMaria A Jacome, Robert J Macaulay, Edwin Peguero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I StudyDmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Journal of Clinical Medicine|July 2, 2020
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade GliomaDaniel J Glazar, G Daniel Grass, John A Arrington, et al.
Oncotargets and Therapy|September 13, 2022
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple MyelomaSyeda Saba Kareem, Neena Viswanathan, Solmaz Sahebjam, et al.
Human Mutation|April 23, 2002
GJB2 mutations in Iranians with autosomal recessive non-syndromic sensorineural hearing lossHossein Najmabadi, Robert A Cucci, Solmaz Sahebjam, et al.
BMC Health Services Research|April 18, 2021
A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumorMaija Reblin, Dana Ketcher, Rachael McCormick, et al.
Neuro-Oncology Advances|April 11, 2022
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, David A Reardon, John H Sampson, et al.
Research Square|October 4, 2023
Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade GliomaHarshan Ravi, Samuel H Hawkins, Olya Stringfield, et al.
World Neurosurgery|February 9, 2021
A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA-Induced Fluorescence in High-Grade GliomasMichael A Vogelbaum, Derek Kroll, Arnold Etame, et al.
Journal of Neuro-Oncology|July 21, 2025
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023Melanie Alfonzo Horowitz, Marvin Li, Megan Parker, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|December 8, 2025
Successful response in advanced leptomeningeal disease from pleomorphic xanthoastrocytoma with BRAF/MEK inhibitors: a case reportMaria A Jacome, Robert J Macaulay, Edwin Peguero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I StudyDmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Journal of Clinical Medicine|July 2, 2020
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade GliomaDaniel J Glazar, G Daniel Grass, John A Arrington, et al.
Oncotargets and Therapy|September 13, 2022
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple MyelomaSyeda Saba Kareem, Neena Viswanathan, Solmaz Sahebjam, et al.
Human Mutation|April 23, 2002
GJB2 mutations in Iranians with autosomal recessive non-syndromic sensorineural hearing lossHossein Najmabadi, Robert A Cucci, Solmaz Sahebjam, et al.
BMC Health Services Research|April 18, 2021
A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumorMaija Reblin, Dana Ketcher, Rachael McCormick, et al.
Neuro-Oncology Advances|April 11, 2022
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, David A Reardon, John H Sampson, et al.
Research Square|October 4, 2023
Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade GliomaHarshan Ravi, Samuel H Hawkins, Olya Stringfield, et al.
World Neurosurgery|February 9, 2021
A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA-Induced Fluorescence in High-Grade GliomasMichael A Vogelbaum, Derek Kroll, Arnold Etame, et al.
Journal of Neuro-Oncology|July 21, 2025
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023Melanie Alfonzo Horowitz, Marvin Li, Megan Parker, et al.
Pageof 9